Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
30 November 2020 | Story Nonsidiso Qwabe | Photo Supplied

Acclaimed South African writer, author, and UFS research fellow Zubeida Jaffer was honoured with a lifetime achievement award for her career in journalism during the Standard Bank Sivukile Awards ceremony. 

Passion for journalism spans decades
During the award ceremony on 15 October 2020, Jaffer received the prestigious Allan Kirkland Soga Lifetime Achievement Award, which recognises a sustained and extraordinary contribution to journalism. Jaffer said she never chose journalism, but journalism chose her. She said when she first stepped into a newsroom looking for a holiday job in the 1970s, she did not know she had stepped into her future in news reporting. Since then, Jaffer has earned many accolades in the journalism industry as well as in academia. She also became an acclaimed author, and wrote her third book, Beauty of the Heart: The Life and Times of Charlotte Mannya Maxeke, during her time as a writer-in-residence at the UFS. While at the UFS, she founded the online media platform, The Journalist, a platform that provides history and context for key issues facing South African journalists. This portal also links students with academics across the country and will soon be extended to the African continent and the diaspora.

Jaffer said she felt blessed to be recognised among the many journalism pioneers in South Africa. 

“It’s extremely wonderful because it came so out of the blue. This year, with COVID-19, I was digging deep, and trying my best to keep focus. I’m very thankful. It’s made me pause, reflect, and realise that a lot of things I’ve done have been of value. When living your life, it’s not that you’re aware of that all the time. There are many people doing great things who don’t always get this kind of recognition,” Jaffer said.

Still a great need for journalists in South Africa 

Talking about journalism today, Jaffer said: “I am often overwhelmed to witness the enthusiasm and determination of young journalists across the country who come from humble backgrounds and inspire those around them. Our country is gripped in a bipolar condition. It is not clear how the healing will come, but it will. The challenge is to keep our minds in balance so that we can be strong enough to root out corruption and gender-based violence, while at the same time fully understanding our blessings as a people.”

UFS alumna Rising Star in Journalism 

In another accolade for the UFS, the Upcoming/Rising Star of the Year award went to former UFS Journalism student Brümilda Swartbooi for her article titled ‘Sy het hard vir ons gewerk’. The article highlighted the senseless killing of a woman outside her workplace, minutes after her husband dropped her off.

Brümilda Swartbooi. Photo: Supplied

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept